Depression Treatment Support App 'Lifton D®' Approved for Evaluation Therapy
Key facts
- Depression Treatment Support App 'Lifton D®' Approved for Evaluation Therapy
- The smartphone app 'Lifton D®,' provided by DT Axis Inc., has been approved for evaluation therapy starting June 1, 2026.
- Source: PR Times
- Date: June 2, 2026
Direct answer
The smartphone app 'Lifton D®,' provided by DT Axis Inc., has been approved for evaluation therapy starting June 1, 2026.
- Citation
- Depression Treatment Support App 'Lifton D®' Approved for Evaluation Therapy (June 2, 2026), PR Times
- Source
- PR Times
- Date
- June 2, 2026
The smartphone app 'Lifton D®,' provided by DT Axis Inc., has been approved for evaluation therapy starting June 1, 2026.
📋 Article Processing Timeline
- 📰 Published: June 2, 2026 at 23:00
- 🔍 Collected: June 2, 2026 at 14:20
- 🤖 AI Analyzed: June 2, 2026 at 14:22 (1 min after Collected)
DT Axis Inc.'s medical device program 'Lifton D®' has been designated for evaluation therapy. The app aims to alleviate symptoms in patients with moderate to severe depression who do not respond sufficiently to medication. Evaluation therapy is a system intended to pave the way for future insurance coverage; usage requires procedures at medical institutions, and costs are borne by the patient. The program runs until May 31, 2030.
FAQ
Are there similar apps in Taiwan?
Digital healthcare regulations are advancing in Taiwan, but the regulatory framework differs.
What are the key facts in this article?
The smartphone app 'Lifton D®,' provided by DT Axis Inc., has been approved for evaluation therapy starting June 1, 2026.
What is the direct answer?
The smartphone app 'Lifton D®,' provided by DT Axis Inc., has been approved for evaluation therapy starting June 1, 2026.